Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTIS trial in diffuse systemic sclerosis
ISRCTN54371254Phase 3Completed
- Sponsor
- EBMT
- Start
- Mar 2001
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide, filgrastim and antithymocyte globulin rabbit in systemic sclerosis (SSc) (2 arms), sponsored by EBMT. Primary endpoint: Event-free survival. Started Mar 2001; status: completed.
02
Drugs
cyclophosphamidefilgrastimantithymocyte globulin rabbit
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on ISRCTN54371254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54371254.